Tumour immunology: TIM3 suppresses antitumour DCs

Comment

Gemma K Alderton. Nat Rev Immunol. 2012 Sep.

. 2012 Sep;12(9):620-1.

doi: 10.1038/nri3288.

No abstract available

Republished from

Immunology: TIM3 suppresses antitumour DCs.
Alderton GK. Alderton GK. Nat Rev Cancer. 2012 Sep;12(9):584. doi: 10.1038/nrc3349. Nat Rev Cancer. 2012. PMID: 22918413 No abstract available.

Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1.
Chiba S, Baghdadi M, Akiba H, Yoshiyama H, Kinoshita I, Dosaka-Akita H, Fujioka Y, Ohba Y, Gorman JV, Colgan JD, Hirashima M, Uede T, Takaoka A, Yagita H, Jinushi M. Chiba S, et al. Nat Immunol. 2012 Sep;13(9):832-42. doi: 10.1038/ni.2376. Epub 2012 Jul 29. Nat Immunol. 2012. PMID: 22842346 Free PMC article.